Answers are grounded in this paper and cite their sources.
This review highlights advances in nanomaterials for neuromodulation, suggesting implications for tailored brain therapies.
This review surveys recent advances in active nanomaterials for neuromodulation, with a focus on remotely controlled nanotransducers for precise manipulation of brain functions. We discuss how stimuli-responsive nanomaterials enable spatiotemporally precise brain interfacing through remotely controlled actuation; furthermore, we examine energy transduction mechanisms underlying nanoparticle-assisted neuromodulation, and highlight nanosensors that monitor bioelectrical and neurochemical activity with high spatial and temporal resolution. Beyond neurons, we consider strategies targeting glial function, as well as emerging approaches to cross or bypass the blood-brain barrier. Finally, we outline key challenges for clinical translation, including long-term safety, biointegration, and regulatory considerations. Together, these developments position smart nanotechnologies as a foundation for next-generation precision brain interfacing, with the potential to design patient-tailored therapeutic solutions across neurological and psychiatric disorders.
No takes yet. Share an insight, caveat, or question.
Curiale et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: